|Bid||34.80 x 800|
|Ask||35.02 x 1100|
|Day's Range||34.50 - 35.22|
|52 Week Range||21.36 - 39.00|
|Beta (5Y Monthly)||1.86|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 01, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||46.14|
Subscribe to Yahoo Finance Plus to view Fair Value for EVH
The consensus price target hints at a 28.3% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
The healthcare services provider recorded beats on both the top and bottom lines in its latest quarterly report.